Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemofilter Life Span and Filtration of Inflammatory Markers in Patients Receiving Extracorporeal Life Support And/or Continuous Renal Replacement Therapy

NCT04193865 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT04193865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04193865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemofilter Life Span and Filtration of Inflammatory Markers in Patients Receiving Extracorporeal Life Support And/or Continuous Renal Replacement Therapy
Lead sponsor
Medical University of South Carolina
Phase
Observational
Overall status
Completed
Start date
January 9, 2020
Completion date
March 25, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute injury of kidney, kidney diseases, neonatal renal disorder (disorder), renal failure, renal insufficiency